Matthew Taylor
Stock Analyst at Jefferies
(3.37)
# 1,020
Out of 5,124 analysts
183
Total ratings
61.26%
Success rate
11.12%
Average return
Main Sectors:
Stocks Rated by Matthew Taylor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GEHC GE HealthCare Technologies | Maintains: Buy | $95 → $105 | $82.02 | +28.02% | 3 | Dec 11, 2025 | |
| PODD Insulet | Maintains: Neutral | $320 → $355 | $284.24 | +24.89% | 16 | Nov 7, 2025 | |
| EW Edwards Lifesciences | Upgrades: Buy | $80 → $98 | $85.25 | +14.96% | 20 | Oct 29, 2025 | |
| SI Shoulder Innovations | Initiates: Buy | $19 | $14.30 | +32.87% | 1 | Aug 25, 2025 | |
| ABT Abbott Laboratories | Upgrades: Buy | $143 → $145 | $125.29 | +15.73% | 17 | Jul 18, 2025 | |
| INMD InMode | Maintains: Hold | $16 → $15 | $14.69 | +2.11% | 7 | Apr 14, 2025 | |
| MDT Medtronic | Maintains: Sell | $75 → $76 | $96.06 | -20.88% | 17 | May 24, 2024 | |
| ALUR Allurion Technologies | Initiates: Buy | $125 | $1.23 | +10,062.60% | 1 | Feb 9, 2024 | |
| MASI Masimo | Downgrades: Hold | $107 → $121 | $130.12 | -7.01% | 9 | Jan 30, 2024 | |
| OBIO Orchestra BioMed Holdings | Initiates: Buy | $14 | $4.15 | +237.35% | 1 | Jan 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $47 → $45 | $21.98 | +104.73% | 2 | Oct 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underperform | $10 | $5.52 | +81.16% | 1 | Jul 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $58 → $53 | $12.42 | +326.73% | 2 | Jul 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $22 → $24 | $11.65 | +106.01% | 2 | May 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $320 → $345 | $351.47 | -1.84% | 14 | May 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Hold | $115 → $130 | $89.92 | +44.57% | 8 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $230 | $310.91 | -26.02% | 1 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $19.72 | +1.42% | 1 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $85 | $40.60 | +109.36% | 1 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $75 | $87.31 | -14.10% | 7 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $245 | $240.87 | +1.71% | 7 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $62 | $19.11 | +224.44% | 8 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $210 | $122.04 | +72.07% | 1 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $21.04 | -42.97% | 1 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $125 | $66.37 | +88.34% | 12 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $50 | $95.35 | -47.56% | 1 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $210 | $566.36 | -62.92% | 12 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $96 | $61.53 | +56.03% | 3 | Feb 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $7 | $3.80 | +84.21% | 1 | Dec 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $266 | $194.07 | +37.06% | 4 | May 13, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $17 → $16 | $12.84 | +24.61% | 2 | Jul 19, 2017 |
GE HealthCare Technologies
Dec 11, 2025
Maintains: Buy
Price Target: $95 → $105
Current: $82.02
Upside: +28.02%
Insulet
Nov 7, 2025
Maintains: Neutral
Price Target: $320 → $355
Current: $284.24
Upside: +24.89%
Edwards Lifesciences
Oct 29, 2025
Upgrades: Buy
Price Target: $80 → $98
Current: $85.25
Upside: +14.96%
Shoulder Innovations
Aug 25, 2025
Initiates: Buy
Price Target: $19
Current: $14.30
Upside: +32.87%
Abbott Laboratories
Jul 18, 2025
Upgrades: Buy
Price Target: $143 → $145
Current: $125.29
Upside: +15.73%
InMode
Apr 14, 2025
Maintains: Hold
Price Target: $16 → $15
Current: $14.69
Upside: +2.11%
Medtronic
May 24, 2024
Maintains: Sell
Price Target: $75 → $76
Current: $96.06
Upside: -20.88%
Allurion Technologies
Feb 9, 2024
Initiates: Buy
Price Target: $125
Current: $1.23
Upside: +10,062.60%
Masimo
Jan 30, 2024
Downgrades: Hold
Price Target: $107 → $121
Current: $130.12
Upside: -7.01%
Orchestra BioMed Holdings
Jan 19, 2024
Initiates: Buy
Price Target: $14
Current: $4.15
Upside: +237.35%
Oct 2, 2023
Maintains: Buy
Price Target: $47 → $45
Current: $21.98
Upside: +104.73%
Jul 19, 2023
Initiates: Underperform
Price Target: $10
Current: $5.52
Upside: +81.16%
Jul 12, 2023
Upgrades: Buy
Price Target: $58 → $53
Current: $12.42
Upside: +326.73%
May 24, 2023
Maintains: Hold
Price Target: $22 → $24
Current: $11.65
Upside: +106.01%
May 2, 2023
Maintains: Buy
Price Target: $320 → $345
Current: $351.47
Upside: -1.84%
Mar 31, 2023
Upgrades: Hold
Price Target: $115 → $130
Current: $89.92
Upside: +44.57%
Oct 12, 2022
Initiates: Buy
Price Target: $230
Current: $310.91
Upside: -26.02%
Oct 12, 2022
Initiates: Buy
Price Target: $20
Current: $19.72
Upside: +1.42%
Oct 12, 2022
Initiates: Hold
Price Target: $85
Current: $40.60
Upside: +109.36%
Oct 12, 2022
Initiates: Buy
Price Target: $75
Current: $87.31
Upside: -14.10%
Oct 12, 2022
Initiates: Hold
Price Target: $245
Current: $240.87
Upside: +1.71%
Oct 12, 2022
Initiates: Hold
Price Target: $62
Current: $19.11
Upside: +224.44%
Oct 12, 2022
Initiates: Hold
Price Target: $210
Current: $122.04
Upside: +72.07%
Oct 12, 2022
Initiates: Buy
Price Target: $12
Current: $21.04
Upside: -42.97%
Oct 12, 2022
Initiates: Buy
Price Target: $125
Current: $66.37
Upside: +88.34%
Oct 12, 2022
Initiates: Buy
Price Target: $50
Current: $95.35
Upside: -47.56%
Oct 12, 2022
Initiates: Hold
Price Target: $210
Current: $566.36
Upside: -62.92%
Feb 24, 2022
Upgrades: Buy
Price Target: $96
Current: $61.53
Upside: +56.03%
Dec 17, 2021
Initiates: Neutral
Price Target: $7
Current: $3.80
Upside: +84.21%
May 13, 2019
Upgrades: Overweight
Price Target: $266
Current: $194.07
Upside: +37.06%
Jul 19, 2017
Maintains: Equal-Weight
Price Target: $17 → $16
Current: $12.84
Upside: +24.61%